<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Access To Justice &#187; Dangerous Drugs</title>
	<atom:link href="http://www.sokolovelaw.com/blog/category/dangerous-drugs/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.sokolovelaw.com/blog</link>
	<description>Powered by Sokolove Law</description>
	<lastBuildDate>Thu, 10 Mar 2011 19:22:38 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Dilantin Must Carry Warning About Purple Glove Syndrome, Says FDA</title>
		<link>http://www.sokolovelaw.com/blog/2010/11/05/dilantin-must-carry-warning-about-purple-glove-syndrome-says-fda/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/11/05/dilantin-must-carry-warning-about-purple-glove-syndrome-says-fda/#comments</comments>
		<pubDate>Fri, 05 Nov 2010 21:29:35 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Dilantin]]></category>
		<category><![CDATA[Purple Glove Syndrome]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=3909</guid>
		<description><![CDATA[
			
				
			
		
The Food and Drug Administration advisory committee recently recommended that the anti-seizure intravenous injection of phenytoin, marketed under the brand name Dilantin, can remain on the market but should carry a warning that it can cause Purple Glove Syndrome. Purple Glove Syndrome (PGS) is a skin disorder in which victims develop swollen and painful hands [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/11/05/dilantin-must-carry-warning-about-purple-glove-syndrome-says-fda/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Statute of Limitations Approaching in Many Potential Reglan Cases</title>
		<link>http://www.sokolovelaw.com/blog/2010/11/01/statute-of-limitations-approaching-in-many-potential-reglan-cases/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/11/01/statute-of-limitations-approaching-in-many-potential-reglan-cases/#comments</comments>
		<pubDate>Mon, 01 Nov 2010 15:17:42 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Reglan]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=3885</guid>
		<description><![CDATA[
			
				
			
		
The two year statute of limitations in a number of states is approaching for filing Reglan cases.  Reglan (metoclopramide) is a prescription medication that can be used to treat a number of gastrointestinal illnesses in children and adults including gastroesophageal reflux (GER) and gastroesophageal reflux disease (GERD).  Unfortunately, Reglan use has been linked to Tardive [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/11/01/statute-of-limitations-approaching-in-many-potential-reglan-cases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Heparin in the News Again after Seven Lots Recalled</title>
		<link>http://www.sokolovelaw.com/blog/2010/10/29/heparin-in-the-news-again-after-seven-lots-recalled-2/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/10/29/heparin-in-the-news-again-after-seven-lots-recalled-2/#comments</comments>
		<pubDate>Fri, 29 Oct 2010 17:35:13 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[B.Braun Medical]]></category>
		<category><![CDATA[Heparin]]></category>
		<category><![CDATA[OSCS]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=3880</guid>
		<description><![CDATA[
			
				
			
		
On Wednesday, October 27, 2010 B. Braun Medical voluntarily recalled seven lots of its injectable blood thinner heparin citing concerns that they may have been tainted with small amounts of oversulfated chondroitin sulfate (OSCS).  Both heparin and OSCS may sound familiar because OSCS is the same substance behind a 2008 heparin disaster resulting in 80 [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/10/29/heparin-in-the-news-again-after-seven-lots-recalled-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Warns AMAG Pharmaceuticals on Website Info</title>
		<link>http://www.sokolovelaw.com/blog/2010/10/28/fda-warns-drug-co-over-misleading-info-on-website/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/10/28/fda-warns-drug-co-over-misleading-info-on-website/#comments</comments>
		<pubDate>Thu, 28 Oct 2010 21:16:25 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[warning letter]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=3875</guid>
		<description><![CDATA[
			
				
			
		
On October, 18th, 2010, the Food and Drug Administration  issued a warning letter to AMAG Pharmaceuticals Inc. over because the company omitted the risks of the drugs on the company&#8217;s websites. Ferumoxsil, also known as GastroMARK, is an oral MRI drug used to enhance the delineation of the bowel to distinguish it from organs and [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/10/28/fda-warns-drug-co-over-misleading-info-on-website/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>More Accutane Lawsuits Added to Mass Tort</title>
		<link>http://www.sokolovelaw.com/blog/2010/10/22/more-accutane-lawsuits-added-to-mass-tort/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/10/22/more-accutane-lawsuits-added-to-mass-tort/#comments</comments>
		<pubDate>Fri, 22 Oct 2010 21:10:05 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Personal Injury Law News]]></category>
		<category><![CDATA[Accutane attorney]]></category>
		<category><![CDATA[Alabama accutane attorney]]></category>
		<category><![CDATA[Roche]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=3849</guid>
		<description><![CDATA[
			
				
			
		
Hundreds more lawsuits were recently added to the New Jersey mass tort case against Roche, the maker of the acne drug Accutane.  The suit alleges that Roche failed to adequately warn Accutane users of the potentially serious side effects including Crohn’s disease, ulcerative colitis, and inflammatory bowel syndrome.  To date, there have been seven trials, [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/10/22/more-accutane-lawsuits-added-to-mass-tort/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Physicians and Pharmaceutical Prescription Practices</title>
		<link>http://www.sokolovelaw.com/blog/2010/10/20/physicians-and-pharmaceutical-prescription-practices/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/10/20/physicians-and-pharmaceutical-prescription-practices/#comments</comments>
		<pubDate>Wed, 20 Oct 2010 15:35:29 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Medical Malpractice]]></category>
		<category><![CDATA[Personal Injury Law News]]></category>
		<category><![CDATA["Dollars for Docs" database]]></category>
		<category><![CDATA[Dangerous Drug Attorney]]></category>
		<category><![CDATA[NPR]]></category>
		<category><![CDATA[ProPublica]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=3842</guid>
		<description><![CDATA[
			
				
			
		
National Public Radio (NPR) has teamed up with ProPublica, an independent, nonprofit newsroom that produces investigative journalism in the public interest, to examine pharmaceutical companies and whether payments to physicians are influencing physician prescription practices.  ProPublica has created a database of payments to physicians compiled from disclosures by seven pharmaceutical companies to help patients make [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/10/20/physicians-and-pharmaceutical-prescription-practices/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Duragesic Pain Patch at Center of Recently Settled Malpractice Lawsuit</title>
		<link>http://www.sokolovelaw.com/blog/2010/10/15/duragesic-pain-patch-at-center-of-recently-settled-malpractice-lawsuit/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/10/15/duragesic-pain-patch-at-center-of-recently-settled-malpractice-lawsuit/#comments</comments>
		<pubDate>Fri, 15 Oct 2010 21:10:51 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Medical Malpractice]]></category>
		<category><![CDATA[Personal Injury Law News]]></category>
		<category><![CDATA[Product Liability]]></category>
		<category><![CDATA[Duragesic Pain Patch]]></category>
		<category><![CDATA[Fentanyl]]></category>
		<category><![CDATA[Rehabilitation Institute of Chicago.]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=3824</guid>
		<description><![CDATA[
			
				
			
		
A medical malpractice lawsuit filed against the Rehabilitation Institute of Chicago on behalf of Kerry Rupright has just settled for $3.75 million.  The sum was awarded to Kerry Rupright’s husband and sons after she died in 2004 at the hospital due to a mishandling of a Duragesic (fentanyl) patch.  The patch is used to treat [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/10/15/duragesic-pain-patch-at-center-of-recently-settled-malpractice-lawsuit/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fosamax Bellwether Cases Continue</title>
		<link>http://www.sokolovelaw.com/blog/2010/10/13/fosamax-cases-continue/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/10/13/fosamax-cases-continue/#comments</comments>
		<pubDate>Wed, 13 Oct 2010 20:36:14 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Personal Injury Law News]]></category>
		<category><![CDATA[Florida Fosamax Attorney]]></category>
		<category><![CDATA[Fosamax]]></category>
		<category><![CDATA[Fosamax Attorney]]></category>
		<category><![CDATA[osteonecrosis]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=3820</guid>
		<description><![CDATA[
			
				
			
		
Bellwether cases continue against Merck and Co. concerning its osteoporosis drug Fosamax.  In June of this year, a jury awarded $8 million to former Fosamax user Shirley Boles, 72, finding Merck &#38; Co. liable for Ms. Boles’ osteonecrosis, a bone rotting condition in her jaw.  Boles’ victory was the first for plaintiffs that [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/10/13/fosamax-cases-continue/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prempro Remains on the Hot Seat</title>
		<link>http://www.sokolovelaw.com/blog/2010/10/07/prempro-remains-on-the-hot-seat/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/10/07/prempro-remains-on-the-hot-seat/#comments</comments>
		<pubDate>Thu, 07 Oct 2010 16:53:46 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Personal Injury Law News]]></category>
		<category><![CDATA[Prempro]]></category>
		<category><![CDATA[Wyeth]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=3812</guid>
		<description><![CDATA[
			
				
			
		
A lawsuit filed by an Arkansas woman has once again brought Pfizer’s Prempro to the forefront as a potentially dangerous drug.  Margaret Wilson’s case claims that Wyeth Pharmaceuticals, a subsidiary of Pfizer, knew that women taking its Prempro hormone-replacement drug were at an increased risk for breast cancer yet failed to change the warning label.  [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/10/07/prempro-remains-on-the-hot-seat/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Novartis Agrees to $422.5 Million Settlement Concerning Six Drugs</title>
		<link>http://www.sokolovelaw.com/blog/2010/10/01/novartis-agrees-to-422-5-million-settlement-concerning-six-drugs/</link>
		<comments>http://www.sokolovelaw.com/blog/2010/10/01/novartis-agrees-to-422-5-million-settlement-concerning-six-drugs/#comments</comments>
		<pubDate>Fri, 01 Oct 2010 20:53:37 +0000</pubDate>
		<dc:creator>Sokolove Staff</dc:creator>
				<category><![CDATA[Dangerous Drugs]]></category>
		<category><![CDATA[Personal Injury Law News]]></category>
		<category><![CDATA[Novartis]]></category>

		<guid isPermaLink="false">http://www.sokolovelaw.com/blog/?p=3782</guid>
		<description><![CDATA[
			
				
			
		
Drugmaker Novartis has agreed to pay a total of $422.5 million in a settlement concerning its marketing of Trileptal, an anti-seizure medicine, and five other drugs.  The Swiss drug company is accused of a number of illegal wrongdoings.  Novartis has pled guilty to a misdemeanor and a $185 million charge for illegally promoting Trileptal for [...]]]></description>
		<wfw:commentRss>http://www.sokolovelaw.com/blog/2010/10/01/novartis-agrees-to-422-5-million-settlement-concerning-six-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
